Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Gastroenterology | Family Medicine

Nephropathy Clinical Trials

A listing of Nephropathy medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 Last 

Alabama

Site Reference ID/Investigator# 105317
Birmingham Alabama 35211
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 111218
Mobile Alabama 36617
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Arizona

Site Reference ID/Investigator# 106300
Peoria Arizona 85381
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107196
Phoenix Arizona 85032
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 118549
Prescott Arizona 86301
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 110376
Tucson Arizona 85712
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Arkansas

Site Reference ID/Investigator# 107678
Little Rock Arkansas 72223
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

California

Site Reference ID/Investigator# 99948
Alhambra California 91801
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 101579
Azusa California 91702
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96605
Azusa California 91702
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 114816
Bakersfield California 93309
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99975
Chula Vista California 91911
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

View More »

Site Reference ID/Investigator# 96591
Chula Vista California 91910
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105566
Downey California 90241
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 101476
Fullerton California 92835
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 118555
Glendale California 91204
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96597
La Mesa California 91942
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 123260
Long Beach California 90822
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104915
Los Angeles California 90059
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96596
Los Angeles California 90022
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99397
Los Angeles California 90036
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96704
Mission Hills California 91345
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 102095
North Hollywood California 91606
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105199
Norwalk California 90650
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107200
Orange California 92868
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96702
Palm Springs California 92262
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 110415
Paramount California 90723
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105576
Porterville California 93257
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107455
Riverside California 92505
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104900
Sacramento California 95825
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105316
San Diego California 92123
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105439
San Francisco California 94110
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96640
Santa Barbara California 93110
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Connecticut

Site Reference ID/Investigator# 111219
New Haven Connecticut 06510
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104911
Stamford Connecticut 06902
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Delaware

Site Reference ID/Investigator# 106297
Newark Delaware 19713
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

District of Columbia

Site Reference ID/Investigator# 96707
Washington District of Columbia 20037
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Florida

Site Reference ID/Investigator# 117452
Aventura Florida 33180
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 116155
Bradenton Florida 34208
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 121136
Brandon Florida 33511
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105438
Coral Springs Florida 33071
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105315
Fort Myers Florida 33912
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

View More »

Site Reference ID/Investigator# 118546
Gainesville Florida 32609
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 116195
Hialeah Florida 33012
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99897
Kissimmee Florida 34741
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 118315
Miami Florida 33122
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 111220
Miami Florida 33015
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 111221
Orlando Florida 32806
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 120275
Ormond Beach Florida 32174
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 116895
Panama City Florida 32401
Updated

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

First 1 2 3 4 5 6 7 8 9 10 11 12 Last